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ABSTRACT 
 
Ibuprofen Administered Pre- or Post- Simulated Resistance Exercise Training Does Not  
Diminish Gains in Bone Formation or Bone Mass. (December 2011) 
David Arthur Cunningham, B.S., Ohio University 
Chair of Advisory Committee: Dr. Susan Bloomfield 
 
 Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to suppress 
bone formation when administered before, but not if administered after, an acute bout of 
mechanical load in rats.  The aim of this study was to test the hypothesis that gains in 
bone mass and size will be diminished in adult rats given ibuprofen before, but not after, 
each exercise bout during 20 days of simulated resistance training (SRT).  Virgin female 
Sprague-Dawley rats (5-mo-old, n=29) completed 9 SRT sessions using stimulated 
muscle contractions under anesthesia at 75% peak isometric strength on alternate days.  
Animals were blocked assigned by body weight to one of three groups: 1) ibuprofen 
(30mg/kg) before exercise, placebo after (I:P)(n=9), 2) placebo before, ibuprofen after 
(P:I)(n=10) and 3) placebo before and after (P:P)(n=10).  In vivo pQCT scans measured 
changes in total volumetric bone mineral density (vBMD) and total bone mineral content 
(BMC) at the proximal tibia (cancellous), and total vBMD, total BMC and total area at 
midshaft tibia on days  -7 and 21.  Dynamic histomorphometry on both midshaft tibiae 
(exercised and non-exercised legs) determined mineralizing surface (MS/BS), mineral 
apposition rate (MAR) and bone formation rate (BFR) on the periosteal surface.  There 
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were no differences in body weights among groups at baseline or at day 21. There were 
significant gains due to SRT, but not ibuprofen treatment in total BMC (+10.50 ± S.D. 
+8.15%) and total vBMD (+5.29 ± 3.41%) at the proximal tibia.  The midshaft tibia 
exhibited significant gains in total vBMD (6.68 ± 3.03%), total BMC (19.18 ± 5.51%) 
and total area (11.68 ± 5.49%) due solely to SRT.  Furthermore, there were significant 
increases in periosteal BFR (pre 21.89 µm3/µm2/d ±2.63; post 717.81 µm3/µm2/d 
±100.57) at the midshaft tibia in the exercised vs. non-exercised legs in all groups but no 
effect of ibuprofen regimen was detected on these indices of bone formation.  Within 
this simulated resistance protocol, we were unable to detect any impact of ibuprofen 
administration on the response to bone loading.   
Supported by Huffines Institute of Sports Medicine and Human Performance, 
Texas A&M University. 
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CHAPTER I 
INTRODUCTION  
 The use of non-steroidal anti-inflammatory drugs (NSAIDs) is a common over 
the counter drug used by millions across the globe for musculoskeletal pain and 
inflammation. The use of these drugs, however, has been shown to reduce the anabolic 
response to bone after an acute bout of exercise in animal models [1, 2, 3].  The main 
therapeutic action of NSAIDs is through the inhibition of cyclooxygenase-2 (COX-2), 
the known enzyme which synthesizes prostaglandin E2 (PGE2) in response to mechanical 
load.  Ongoing studies have identified various mechanisms by which mechanically-
induced PGE2 is thought to have its effect on bone formation.  Those studies were 
focused on an acute bout of exercise and have yet to establish the impact of NSAIDs 
with multiple training sessions.  Multiple training sessions is idea because 1) it best 
translates to the lifestyle of an athlete in training and 2) it will translate to therapeutic 
exercise in older adults who regularly use NSAIDS.  Exercise has been shown to 
increase inflammatory cytokines, which have a known catabolic effect on bone.  Thus, 
the use of NSAIDs may have the ability to successfully reduce the increase in 
inflammatory cytokines and, therefore, cytokines’ deleterious effect.  However, the 
timing of NSAIDs administration relative to exercise is critical to ongoing research.  
Previous studies have shown an inhibitory effect to bone formation when NSAIDs are 
administered before an acute load [1, 2, 3]; however, a recent study indicates NSAIDs as 
a potential bone therapeutic drug when administered post- resistance training [4].  
___________ 
This thesis follows the style of Bone. 
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Gaps in knowledge are whether BFR is influenced over multiple sessions in rats when 
given NSAIDs and if this influences overall bone mass and size as seen when ibuprofen 
is given post resistance training in humans [4]?  Lastly, if bone mass is influenced, then 
are these effects inversely related to serum inflammatory cytokine concentration?  
Specific Aims and Hypotheses 
Specific Aim 1: To determine the impact of oral ibuprofen administration given before or 
after exercise on BFR after 3 weeks of simulated resistance training in adult female rats. 
Hypothesis 1:  Bone formation rate will be suppressed over time in adult rats given 
ibuprofen before each training session, but enhanced if ibuprofen is given after each 
exercise bout 
Specific Aim 2:  To determine the impact of oral ibuprofen administration given before 
or after exercise on long-term adaptations in bone mass and geometry after a 3-week 
simulated resistance training (SRT) model in adult rats. 
Hypothesis 2:  Gains in bone mass and increased bone size will be diminished in adult 
rats given ibuprofen before each training session, but enhanced if ibuprofen is given 
after each exercise bout.   
Specific Aim 3:  To determine if the effect of ibuprofen administration given before or 
after exercise on the bone response to 3 weeks of chronic training is related to 
differences in the inflammatory cytokine response to acute exercise bouts. 
Hypothesis 3:   When ibuprofen is administered after exercise, there will be enhanced 
gains in BFR and bone mass due to a decrease of IL-6 following acute exercise when 
compared to ibuprofen administered before exercise and placebo control.  
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CHAPTER II 
REVIEW OF LITERATURE 
Bone Formation and Resorption 
  Bone is a highly dynamic tissue comprised of elastic type I collagen and 
hardened hydroxyapatite crystals.   The combination of these two properties allows bone 
to be both structurally supportive for protection, as well as elastic in order to allow for 
bending and torsion forces on its surfaces.  These forces produced through every day 
activities such as running and jumping, are sensed through a variety of cells within the 
bone matrix.  The main sensing cell to external forces is known as osteocytes.  
Osteocytes are embedded deep within the bone matrix and provide communication to the 
bone surface, whether it is in cancellous, a spongy porous bone located at the end of long 
bones, or cortical bone, a protective compact bone located within the shaft of the long 
bones.  Osteocytes are capable of communicating with bone forming cells known as 
osteoblast and bone resorbing cells known as osteoclast. 
 Osteoblast, the precursor to osteocytes, lay down new bone matrix on the bone 
surface until cell death occurs, where osteoclast located on the cell surface break down 
the bone matrix via acidic secretion.  Bone is considered highly dynamic because it 
constantly undergoing turnover by a balanced rate of formation and resorptionr.  
Generally, bone turnover produces no net gain or loss of bone in healthy individuals.  
However, as individuals age there is no longer a balance between the osteoclasts and 
osteoblast, such that the rate of bone resorption exceeds the rate of bone formation due 
to increased osteoclast production and activity, thus causing a total net loss of bone.  On 
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the contrary, as an individual becomes more active, they experience more impact on the 
bone, and bone formation rates exceed the rate of resorption due to increased ostoeblast 
production and activity, thus causing a net gain in bone.  A key cytokine in the 
communication between osteocytes, osteoblasts and osteoclast is known as prostaglandin 
E2 (PGE2) and will be described in the preceding sections. 
 
Prostaglandins 
Prostaglandins in bone can stimulate bone formation and bone resorption 
depending on the local concentration. An excessive amount of prostaglandin has the 
ability to stimulate osteoclast for bone resorption, but small local increase in PGE2 
concentration can contribute to bone formation.  Hormonal regulation of bone is possible 
because of an intricate network of osteocyte dendritic processes and gap junctions 
forming a functional syncytium, allowing osteocytes embedded in the calcified bone 
matrix to communicate with each other and with surface osteoblasts [5].  Mechanically-
induced load incurred with weight bearing activities (i.e. resistance training, running and 
jumping) elicits the release of prostaglandins, which has a positive effect on bone mass.  
The production of prostaglandin E2 (PGE2), the main contributor to bone formation, is 
catalyzed by the enzyme cyclooxygenase (COX), which consist of two isoforms, COX-1 
and COX-2 (Fig. 1).  COX-1 is constantly expressed and acts more in a homeostatic or 
cytoprotective manner in most tissues.  COX-2 isoform is absent from most tissues [6] 
and is the main contributor to load-induced PGE2 signaling in bone.  COX-2 is 
inducible, where COX-1 is constitutive with little regulation [7]. 
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Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs   
 In order to study the effects of PGE2 after mechanical loading, research has 
relied heavily upon COX-1 and COX-2 inhibitors known as Non Steroidal Anti-
inflammatory Drugs (NSAIDs).  Commercially, NSAIDs are used as an over-the-counter 
drug to suppress inflammation via reduced synthesis of PGE2 and for incidental and 
chronic musculoskeletal pain in the elderly and athletes.  This has motivated research in 
order to investigate the effect of NSAIDs when taken with exercise.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arachidonic Acid 
COX-1 
COX-2 
NSAIDs 
Fig. 1.  Synthesis of prostaglandin E2 and inhibition via NSAIDs.  
NSAIDs inhibit COX-1 & COX-2 thus decreasing the synthesis of 
PGE2 (image adapted from [8]). 
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Fortunately, there are a variety of NSAIDs available that have various 
specificities to COX-1 or COX-2, which are described as non-selective, or specific COX 
inhibitors.  COX-2 specific NSAIDs target strictly COX-2 and even at the highest does 
COX-1 is unaffected, where as COX-2-selective NSAIDs will have a higher affinity for 
inhibition of COX-2, but higher dose may affect COX-1. Non-selective NSAIDs affect 
preferentially COX-1; however, will affect COX-2 at the same plasma concentration as 
COX-1.  The selectivity of a selective vs. Non-Selective NSAID is established based on 
the COX-1/COX-2 ratio.  The COX-1/COX-2 ratio is expressed as the ratio of the 50% 
inhibitory concentration or inhibitory dose for CO-1 to the 50% inhibitory concentration 
or inhibitory dose for COX-2 (Table 1).  The larger the ratio, the greater affinity of the 
NSAID for COX-2; this ratio will vary on whether the assay was done in vitro or in vivo 
[9].  Th9ese categories of NSAIDs have provided some insight into the impact of 
NSAIDs when delivered before or after an acute bout of mechanical load on bone 
formation. 
 
 
 
 
 
 
 Table 1 
 NSAIDs Selectivity. 
Expressed as the ratio of the 50% inhibitory concentration or inhibitory dose for 
COX-1 to the 50% inhibitory concentration or inhibitory dose for COX-2.   >1 
COX-2 Preference   :   <1 COX-1 Preference (table adapted from [9]). 
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Non Steroidal Anti-Inflammatory Drugs and Mechanical Load 
Mechanical load creates fluid shear stress within the bone lacunae, delivering a 
large stimulus over the entire bone  lining cell, thus resulting in reorganization of the 
actin cytoskeleton in order to stimulate the production of PGE2 [10].  Rawlison et al. 
(1991) [11] have demonstrated a significance increase in PGE2 in less than 5 minutes 
after loading; the elevated levels decrease back to baseline within 15 minutes in vitro 
with osteoblast like cells.  This initial production of prostaglandin during mechanical 
load has been suggested to be a main contributor to the end result: increased bone 
formation [1, 4].  
 Previously, it has been shown that when a non-selective COX inhibitor with a 
COX-1/COX-2 ratio of 2 (indomethacin) [12] is administered 3 hrs before ulna loading, 
with rats there is inhibition of new bone formation; however, if the NSAID is 
administered 6 hours after loading, there is no change in bone formation activity.  This 
suggests there is a specific period of time in which loading induced PGE2 production is 
key in bone formation [1].  It seems as if this effect is due to the rapid production of 
PGE2 at the onset of mechanical load, as previously described.  However, one would 
assume this rapid increase in PGE2 is induced by an up-regulation of COX-2 at the onset 
of mechanical load, but it appears this is not the case [13].  It has been shown that fluid 
shear stress does not up-regulate COX-2 expression until 30-90 minutes post-mechanical 
load in vitro [14] and in vivo [13].   When rats are given the specific COX-2 inhibitor, 
NS-398, there is no significant reduction in load-induced bone formation when the 
inhibitor is given 30 minutes before an acute bout of load, but the expected bone 
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formation reduction does occur when NS-398 is given 3 hours before mechanical load 
[13].  NS-398 peak serum levels occurs at 30 min, so it was hypothesized that the 
inhibitory response to mechanical load will be the same if the NSAID is given 3 hours 
before or 30 min before load.   The authors speculate this may be due to recent findings 
in vitro that mechanical loading affects the intracellular secretion of prostaglandin and 
not the new synthesis of prostaglandin [15], thus indicating the suppression of 
prostaglandin synthesis must occur well before the time of loading.  For an overview of 
the previous section please refer to Fig. 2. 
 
 
 
  
 
 
 
 
 
Inflammatory Cytokines 
The timing at which NSAIDs are administered, pre or post induced load, in an 
acute bout of exercise will have a profound effect on the ability to benefit loading-
induced bone formation.  If NSAID administration is translated to a human model, 
chronic NSAID use may largely negate the benefits of weight bearing activity on bone 
Fig. 2. Impact of the timing of NSAIDs administration relative to an acute 
bout of mechanical load on BFR (↑ = increase in bone formation; ↓ = 
decrease in bone formation; NC = no change in bone formation). 
Acute Load 
BFR (NS-398): NC 
 [13] 
In vitro  
PGE2 [11] 
BFR (indo): NC 
 [1] BFR: Indo [6] 
          NS-398 [12] 
3 hrs 30 min  15 min  6 hrs  
In vitro  
PGE2 [11] 
5 min  
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health.  However, as mentioned, previously published studies examine responses to only 
an acute bout of exercise, as opposed to multiple training sessions.  One notable 
consideration is the large increase in inflammatory cytokines post-exercise [16, 17].  
Inflammatory cytokines have the ability to stimulate bone resorption activity via 
enhanced osteoclast differentiation and increased activity of mature osteoclasts [18, 15]. 
An acute bout of exercise stimulates both increased bone resorption and increased 
formation; increases in resorption may be induced an increase in inflammatory cytokines 
[4].  Whether exercised induced inflammatory cytokines have the ability to suppress 
bone formation with chronic training has yet to be elucidated.    
The key inflammatory cytokines involved in bone resorption are the interleukins 
(IL-1, IL-6) and tumor necrosis factor (TNF-α) [15].  The effect of these cytokines on 
bone, is mediated by receptor activator for nuclear factor κ B (RANKL) and macrophage 
stimulating factor (M-CSF) produced by osteoblasts for osteoclastogenesis.  IL-1β and 
TNF-α synergize to elicit a marked increase in RANKL levels, thus mediating 
proinflammatory regulation of osteoclast differentiation via RANKL [19, 20].   
IL-6 has no effect on RANKL regulation, thus another pathway must be 
considered.  IL-6 has been shown to indirectly affect bone resorption [20].  It affects 
bone resorption by activating other pro-inflammitory cytokines such as the previously 
mentioned IL-1 and TNF-α [21]. 
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NSAIDs and Chronic Training 
One bout of vigorous resistance exercise in humans can produce a 7-fold increase 
in serum levels of IL-6 by one hour post-exercise [16]. These elevated levels of 
cytokines are thought to be triggered by the leakage of endotoxins (lipopolysaccharides) 
from the intestines [22] as well as from the muscle during exercise [23].  A resistance 
training paradigm can produce an elevated level of inflammatory cytokines [17], thus 
favoring, net bone resorption over a long period of time.  It is hypothesized, over weeks 
and months of training, the balance between bone formation and resorption will be tilted 
towards resorption mediated by inflammatory cytokines effect on osteoclast activity and 
differentiation [24].  The effects of inflammatory cytokines post-exercise are an 
important variable to consider.  The studies of NSAIDs on bone have only looked at an 
acute bout of mechanical load which may not elicit the chronic effects inflammatory 
cytokines on bone due to training. 
The use of NSAIDs post-exercise may help suppress inflammatory cytokines and 
thus tilt the bone formation/resorption balance back in favor of formation.  Enhanced 
gains in bone mineral density have been observed if NSAIDs are administered post-
exercise while training pre-menopausal women.  This response is even greater than the 
typical bone response to mechanical load without NSAID administration [4] (Fig.  3).  
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It may be that the benefits of NSAID use when taken after an exercise session are 
achieved because NSAID’s attenuate the elevation of inflammatory cytokines levels and 
therefore suppress the acute post-exercise resorption effect [4].   For example, it has 
been shown in male army recruits genotyped for Il-6-174 G>C polymorphism, that those 
recruits with Il-6 dominant polymorphism lost 6.8% of cortical area post basic training, 
where heterozygotes gained 5.5% and those Il-6 deficient gain 17.3%  in cortical area 
[25] (Fig. 4).   This gives evidence to any decrease in Il-6 post exercise via NSAIDs may 
enhance overall bone formation. 
Fig. 3. Ibuprofen given post resistance training in pre-menopausal women. 
Ibuprofen given post resistance training in premenopausal women have 
enhanced bone mineral density (Image adapted from [4]). 
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In a periodontitis model, NSAIDs (specifically ibuprofen) have been shown to 
slow down the rate of bone loss due to this inflammatory disease [26]. Periodontitis is 
known to increase production of TNF-α and IL-1 via monocytes, IL-1 by oral epithelial 
cells, and IL-6 via many cell types.  Ibuprofen has been shown to augment bone erosion 
via cytokines in rat fetal long bones, but ibuprofen was the least effective NSAID in 
achieving this effect.  Ibuprofen was 700 times less potent than the most effective 
NSAID, ketorolac [27].  Even though NSAID’s have been shown to reduce the 
deleterious effects of inflammatory cytokines on bone, the hypothesis that NSAID 
consumption post-exercise reduces exercise-induced inflammatory cytokines may be 
complicated by evidence of an increase in inflammatory cytokines post competition even 
Fig. 4. Cortical resorption is IL-6 genotype dependent. Il-6-174 
G>C polymorphisms in army recruits cortical area post basic 
training. GG Il-6 dominant, CC Il-6 deficient, GC Il-6 
heterozygote  (Image adapted from [25]). 
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in those consuming ibuprofen after exercise.  Ultramarathon runner [16] who consumed 
ibuprofen showed a 106% increase in lipopolysaccharides, an endotoxin responsible for 
exercise-induced inflammatory cytokines when compared to those who did not consume 
the NSAID.  Ibuprofen has been shown to reduce glomerular filtration rate; thus, 
cytokine clearance from the kidney may be reduced during exercise [28].  These results 
do have their limitations because an ultramarathon is not a typical activity and the event 
is meant to push athletes beyond their limits.  These results do, however, raise questions 
on the effects of chronic use of NSAIDs during training. 
 
Long Term Effects of NSAIDs 
Even though there has been demonstration of enhanced bone mineral density 
response to exercise training with NSAID given after exercise [4], it is important to 
consider the effects of chronic NSAID use in a non-exercise model.  In a 24 week study 
on ovariectomized (OVX) rats treated with indomethacin, a non-specific NSAID, a 
decrease in cancellous bone volume was observed due to a suppression of both bone 
formation and bone resorption.  These results were further confirmed due a decrease in 
BMD and compressive strength of the vertebral body [29].  It has also been 
demonstrated that after 3 weeks of chronic ibuprofen use, a reduction in radial bone 
growth and cancellous bone area of the tibial metaphysis was observed in both ovary 
intact and OVX rats [30].  Despite the potential benefits of NSAIDs use with chronic 
training, further research will have to consider the long term effects of NSAIDs if used 
over a significant period of time. 
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Gaps in Knowledge 
The chronic use of NSAIDs by athletes and everyday Americans in order to treat 
incidental and chronic musculoskeletal pain justifies the need to identify the impact of 
NSAIDs and the timing of administration relative to exercise.  Previous studies have 
identified key time points in which the effect of PGE2 on bone formation is most active 
during and after an exercise bout [1, 12, 13, 14].  The use of NSAIDs may have an 
enhanced effect on bone formation if ingested by chronically trained individuals post-
exercise, perhaps due to NSAIDs ability to suppress inflammatory cytokines induced by 
exercise.  These cytokines are potent molecules which activate bone resorption via 
activation and differentiation of osteoclasts.  Future studies need to identify the effect of 
inflammatory cytokines produced during exercise and their potential inhibitory effect on 
bone.  
 Currently, the gaps in knowledge are whether timing of NSAIDs influence bone 
formation rate (BFR) over multiple sessions in rats and if this can be translated to the 
overall bone mass and size as seen when ibuprofen is given post resistance training in 
humans [4]?  Lastly, if bone mass is influenced, then are these effects inversely related 
to serum inflammatory cytokine concentration?  The aims of this study are to determine 
the impact of ibuprofen on bone response to simulated resistance training and to explore 
altered changes in serum Il-6 as a potential mechanism has on bone health during 
resistance training.   
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CHAPTER III 
METHODS 
General Overview 
Study Design: Female (n =29) Sprague-Dawley rats, 4-mo-old at arrival, were 
housed at the Agronomy Road animal facility, two to a cage, on a 12:12 light:dark cycle.   
After a week of acclimation,  rats were be rank-ordered by body weight and then block 
assigned to one of 3 groups; PP: Placebo before exercise, Placebo after exercise; IP: 
Ibuprofen before exercise, Placebo after exercise; PI: Placebo before exercise, Ibuprofen 
after exercise (Table 2).   This block randomization strategy helps assure groups with 
roughly equal mean body weight, important since bone size scales to total body weight.     
 
Table 2   
Experimental groups (total n = 29). 
Group   Before Ex After Ex 
                                   P:P (n=10) Placebo   Placebo  
                                   I:P  (n=9) Ibuprofen  Placebo 
                                   P:I  (n=10) Placeb   Ibuprofen 
 
Starting at roughly 5 months of age,  rats underwent 9 SRT sessions performed every 
other day at 75% peak isometric strength for 4 sets of 5 repetitions.  All animals received 
about .1 ml of vehicle (0.09% saline) with or without ibuprofen (30mg/kg) by oral 
gavage 2 hours before and immediately after each training session, as detailed below.  
Blood draws were taken pre exercise training in order to obtain baseline IL-6 cytokine 
levels and then 30 min and 90 min post exercise 2 days after baseline was drawn.  For 
full timeline refer to Fig. 5. 
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              Fig. 5. Timeline of study. 
 
In vivo Muscle Stimulation 
  This was accomplished using an adapted version of the miniature isokinetic 
dynamometer originally developed for use in mice by Drs. Gordon Warren and Robert 
Armstrong [31].  We used a miniature isokinetic dynamometer to simulate resistance 
training every other day for 20 days, for a total of 9 training sessions.  After the rat was 
anesthetized with isoflurane, it was placed in right lateral recumbency on the 
dynamometer platform, its foot secured to the servomotor shoe (Fig. 6).  The knee was 
positioned so that the foot was perpendicular to the lower leg and secured with a ball-
jointed clamp system.  Sterilized fine wire (10 cm long; STABLOHM 800B H-ML Size 
003 ---California Fine Wire Co) was stripped of insulation at about 4 mm at both ends 
and inserted thru a 27ga ½” needle and 1.5 mm was bent over at the end to form a 
Day -8 
Pre pQCT 
Pre Blood Draw (BD) 
Day 0 
Start exercise 
Train every other 
day 
Day 2 
Post BD 
30 & 90 min 
Day 11 
Calcein 
Day 12 
Pre BD 
No exercise 
Day 16 
Post BD 
30 & 90 min 
Day 20 
Last exercise session 
Calcein 
Day 21 
Post pQCT  
Sac 
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“barb.”  The leg was extended and the origin of the gastrocnemius muscle on the femur 
was palpated.  The needle containing the wire was inserted straight down to the right of 
the femur and then the needle was withdrawn, leaving the thin wire implanted near the 
nerve with barb on the end. The second wire was implanted @ 4 – 6 mm dorsal to the 
first in the same manner. The stimulation wires were then attached to the output poles of 
a Grass stimulus isolation unit interfaced with a Grass S8 stimulator.  
 
 
 
 The first step in each training session was to optimize the isometric contraction 
torque production by the posterior crural muscles, yielding a peak isometric torque value 
specific to the rat that day.  This was done with 4-5 contractions while adjusting 
stimulation voltage.  The stimulus is 200 ms long using a 175 Hz frequency and 0.1 ms 
biphasic pulses with 45s in between contractions.  A period of 2 minutes rest was given 
once the peak isometric torque was recorded.  Next, 4 sets of 5 eccentric contractions 
Fig. 6. Simulated resistance training device. a.) Anesthetized rat resting on 
simulated resistance training device b.) Isometric and eccentric foot angle 
throughout lower leg muscle contractions. 
a. b 
Isometric Eccentric 
Servormotor 
Anesthetized rat 
Fine wires 
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were performed at 75% of the rats’ peak isometric torque. Peak isometric torque was 
determined to be the maximal isometric torque at the lowest voltage necessary.  Voltage 
frequency was adjusted during the eccentric contraction in order to determine 75% 
isometric torque.  A period of 12 seconds rest was given in between contractions and 
120 seconds rest between each set.  This took approximately 25 minutes.  Contractions 
were performed over a 40° arc using an angular velocity of 200°/s at 180 Hz.  The 
stimulus duration was 2000 ms; 1000ms isometric contraction and 1000ms eccentric 
contraction (Fig . 7).   
 
 
 
 
Ibuprofen Administration 
All animals received 0.1 ml of vehicle (.09% Saline) with or without ibuprofen 
by oral gavage before and immediately after each training session.  Originally, the oral 
Fig. 7. Isometric and eccentric torque outputs. 
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gavage was performed on a concious rat; however, by the third training session all of the 
rats were put under light isoflourene in order to administer the ibuprofen.  Anesthesia 
became necessary because of an unexpected death of a rat due to the rats’ movement 
during oral gavaging.  Rats received a 30 mg/kg dose of ibuprofen.  The literature states 
that a dose between 10mg/kg and 30mg/kg is safe [32].  Previous resarch has effectively 
used 30 mg/kg for fracture healing studies [33, 34] and it has been stated that the 
ulcerogenic dose in rats is 455 mg/kg (4 daily doses) [35]. We gave the rats 30 mg/kg 3 
days a weeks which is well below the 455 mg/kg ulcerogenic dose.  Furthermore, 
fracture healing studies utilize 30mg/kg because Rissing and Buxton (1986) [36] showed 
an effect on the PGE levels assessed by radioimmunoassay in animals treated with 30 
mg/kg/day of ibuprofen in Sprague Dawley rats. 
 
Serum Collection 
   Rats were anesthetized with inhaled isoflurane (to effect) and we tied a 
tourniquet around the upper leg to apply intermediate pressure; the lower leg was shaved 
to aid in visualizing the saphenous vein, and venous blood was collected with a 25 ga 
needle into a microfuge tube.   Blood was obtained from animals pre exercise training 
and 30 and 90 minutes post exercise training during week one and week 3 (Fig. 8).  Once 
the blood clotted, the tubes were centrifuged for about 5 minutes and serum was 
collected and stored at -80º C for further analysis. 
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          Fig. 8.  Blood draw timeline 
 
Calcein Injection 
 On days 2 and 9 before the scheduled sacrifice of each animal, we gave an 
intraperitoneal injection of calcein (using a 25 mg/kg BW solution, which amounts to 0.3 
mL per injection).  Calcein is a relatively inert tetracycline derivative which binds to 
circulating free calcium in the blood.  Any bone surface that is actively mineralizing in 
the 48 hours following each injection incorporates this calcein-labeled calcium, 
producing a fluorescent label along that bone surface when histological sections are later 
viewed under epifluorescent light.  This allows us to quantify the relative bone surface 
that is actively mineralizing and, by measuring the distance between double labels (when 
they occur), to calculate bone formed over that 7-day interval.   
 
Pre Blood 
Draw: No 
exercise  
-8 Days 
Post Blood 
Draw:  30 min 
& 90 min  
+2 Days 
 
Pre Blood 
Draw: No 
exercise  
+12 Days 
Post Blood 
Draw:  30 min 
& 90 min  
+16 Days 
 
Week 1 
Week 3 
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Outcome Measures 
On days -7 and 21, animals were anesthetized and their tibiae were scanned at 
both the proximal and mid-shaft tibial sites using peripheral quantitative computed 
tomography (pQCT; Stratec XCT-M, Norland Corporation) in order to quantitate bone 
mineral content, density and geometry.    About 100-200 uL of serum was collected from 
the saphenous leg vein on Day -7 before the pre-training pQCT scan (to represent basal 
or pre-exercise values) and after a training session in the first and fifth weeks to assess 
serum levels of inflammatory cytokine, Interleukin-6.     Forty-eight hours after the final 
training session (day 21), rats were anesthetized and euthanized by decapitation;  cardiac 
serum was collected, proximal and distal femurs were cleaned of soft tissue, wrapped in 
PBS-soaked gauze and frozen at -80º C until further analysis.  Midshaft femur was snap 
frozen and stored at -80º C for future PCR analysis.  We  stored the tibia in 
paraformaldehyde for 24 hours at 4C and then 70% ethanol at 4C to enable later 
histomorphometric analysis of bone formation rate  and immunohistochemistry analysis.   
 
Histomorphometry Analysis 
  The left distal tibia were sectioned  2.5 mm proximal to the tibial-fibular junction 
with an Isomet diamond wafer low-speed saw (Buehler, Lake Bluff, Il) after the bones 
were embedded in methylmethacrylate (Sigma-Aldrich M5, 590-9).  The distal tibia was 
sectioned to 100µm slices and then mounted on glass slides.  The histomorphometric 
analyses were performed using the OsteoMeasure Analysis System, Version 1.3 
(OsteoMetrics, Atlanta, GA) and a Bx-56 Olympus light microscope with epifluorescent 
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light.  Labeled surfaces and interlable widths were obtained at 200x magnification of1 
slide/section.  Periosteal mineral apposition rates (MAR, µm/d) were calculated by 
dividing the average interlabel width by the time between labels (7 days), and 
mineralizing surface (MS) for both the periosteal and endocortical bone surfaces was 
calculated using the formula: 
%MS/BS = {[(single labeled surface/2) + double labeled surface]/surface perimeter} x 
100.  
Bone formation rate (BFR) was calculated as: 
 BFR= (MAR x %MS/BS) 
Slides were “blinded” so the measurer was not aware to which group each slide 
corresponded. 
 
Peripheral Quantitative Computed Tomography  
  Measures of tibia bone density and geometry were taken in-vivo using our 
peripheral quantitative computed tomography (pQCT) device (XCT Research M Stratec; 
Norland Corp., Fort Atkinson, WI).   The XCT-M pQCT device is interfaced with a 
dedicated PC with a Jazz drive for data archiving.  Animals were anesthetized with 
inhaled isoflurane (to effect) and scan slices were taken at both the metaphyseal (5, 5.5, 
6, 6.5mm from reference) and diaphyseal (50% total bone length) regions, with voxel 
size of 70um (Fig. 9).  Total scan time was approximately 30 minutes from time of scout 
view until scanning was complete.  Data from the three contiguous metaphyseal region 
slices are averaged to get a single value for each variable.  Key outcome variable include  
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total and cortical volumetric bone mineral density (vBMD); total area, cortical area and 
marrow space area, as well as total bone mineral content (BMC). Machine precision 
(based on manufacturer data) is  3 mg/cm3 for cancellous bone and  9 mg/cm3 for 
cortical bone.   In-vivo CV’s from our laboratory using this method at the rat proximal 
tibia (with repositioning between scans) are 2.13% for cancellous vBMD, 0.23% for 
cortical vBMD, 1.95% for total area.  Corresponding CV’s at mid-diapyhisis for the tibia 
are 0.86% for cortical vBMD, 1.09% for cortical area, and 2.42% for marrow area.    
 
 
 
 
Fig. 9. Peripheral quantitative computed tomography (pQCT).   
Stratec XCT-Research M (Norland 
Corporation): 
Scan speed: 2.5 mm/sec 
Voxel resolution: 70 microns 
Slice thickness: 0.5 mm 
Midshaft tibia site location 
Two serial scans taken in vivo at 50% of the 
length of the tibia 
Proximal tibia site location 
Serial scans taken in vivo at 5, 5.5, 6 & 6.5 mm 
distal tibial plateau values averaged from all 4 
sites 
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Interleukin-6 Assay 
   Standard ELISA procedures were used from ImmunoDiagnostics Quantikine (for 
IL-6).  All samples were organized so that any one rat’s samples were assayed with one 
kit. 
 
Statistical Analysis 
  To determine treatment effects and interactions, a two way (Ibuprofen Group x 
time) ANOVA with repeated measures on time was used on variables collected 
longitudinally (pQCT scan parameters, serum values).   Two-way ANOVA were also 
performed on variables determined at sacrifice (e.g. histomorphometry analysis) to study 
comparisons among groups of animals.  Appropriate Tukey post-hoc comparisons were 
used to determine pair-wise differences. All data are reported as means ± S.D. 
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CHAPTER IV 
RESULTS 
Animal Response to Training 
Over the course of the 21 days of exercise training there were no-significant 
differences in mean body weight over the course of 21 days and among the 3 groups (p > 
0.05) (Table 3).  The animals began training at 5 months of age and the non significant 
changes in body mass suggest all animals were mature adult with limited growth over 
the course of the training period.  All animals were fed ad libitum.  
Animals responded well to the training protocol and isoflurane.  Animals woke 
up ~5 min post training and showed no visible signs of injury post training.  Some 
animals developed wheezing due to the ibuprofen entering the trachea while still under 
anesthesia; however, this problem was resolved after we started hold the animals 
vertically immediately after oral gavage in order to keep the ibuprofen contained within 
the stomach.  Rats were held vertically until they showed signs of waking up.    
 
 
 
 
 
 
 
 
 
 
  
Groups 
Days 
-7 0 7 14 21 
PI 280.74 g 285.52 g 279.37 g 280.67 g 275.59 g 
 ±11.57 ±12.12 ±15.56 ±10.97 ±12.09 
PP 281.75 g 274.48 g 271.78 g 284.98 g 279 g 
 ±18.08 ±15.41 ±9.97 ±18.75 ±19.79 
IP 279.97 g 282.48 g 276.62 g 283.83 g 281.66 g 
 ±13.62 ±12.77 ±11.71 ±16.26 ±19.74 
Table 3   
Adult rats over the course of 21 days did not gain or lose body 
weight 
Values are means ± SD. There were no significant changes in 
bodyweights over course of 21 days, nor among groups within time 
points. 
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Mid-Shaft Cortical Bone Mineral Content  
Simulated resistance training had an anabolic effect on the cortical bone mineral 
content of the tibial midshaft (Fig. 10).  Bone mineral content is a measure of the total 
bone mineral present and is an important measure in order to identify any changes in 
bone size and level of mineralization combined.  Simulated resistance training increased 
cortical BMC by 19% (pre: 6.26 mg ± .4; post: 7.45 mg ±.42) (p < 0.05) in the control 
(PP); however, there is no significant difference in gain of BMC among groups (PP, IP 
& PI).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Mid-shaft cortical bone mineral content. Cortical BMC of the midshaft tibia 
before and after 21 days of simulated resistance training.  
 * p<0.05 vs. pre value 
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Mid-Shaft Total Area 
Simulated resistance training had a positive effect on the total area of the 
midshaft tibia cortical bone (Fig. 11).  Although SRT increased total area by 11.4% 
(p<0.05) in the control (PP) there were no significant differences among the IP, PI and 
PP groups’ means. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11. Mid-shaft total area. Total area of the midshaft tibia after 21 days of simulated 
resistance training. The left leg received muscle contraction exercise. 
* p<0.05 vs. pre values 
 
Mid-Shaft Marrow Space Area 
 Simulated resistance training significantly decreased the marrow space area by 
8.5% at the midshaft tibia in the PP and IP groups (Fig. 12) (p<0.05).  A Tukey post-hoc 
test shows that PI marrow space was not significant, but trending towards significance 
with a p value of .06.  A decrease in the marrow space is indicative of an increase in 
endocortical bone formation.  Although there was an overall decrease in marrow space 
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area, there were no significant differences among groups with respect to ibuprofen 
treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12. Mid-shaft marrow space.  Marrow space area of the midshaft tibia after 21 days 
of simulated resistance training. The marrow space significantly decreased with SRT in 
the PP and IP groups and trended in the PI group (p=.06). There were no significant 
differences among groups at either time point.  
 * p<0.05 vs. pre values 
† p<0.06 vs. pre value 
 
 
Proximal Tibia 
The following graphs represent data collected from the proximal tibia for 
exercised leg.  Although the proximal tibia is a mixed bone site (cancellous & cortical), 
the proximal region is largely cancellous bone; hence, alterations in BMC and vBMD 
yield more insight into the cancellous bone rather than the cortical bone presented in the 
previous section. 
 
† 
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Proximal Total Bone Mineral Content  
 A two-way ANOVA analysis shows that, although there was a significant 
increase in BMC due to SRT, there are no significant differences among groups at either 
time point.  Total BMC increased by 10.22% at the proximal tibia within the PP group 
(p<0.05) (Fig. 13). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. Proximal total bone mineral content.  Total BMC of the proximal tibia after 21 
days of simulated resistance training.  
  * p<0.05 vs. pre values 
 
Proximal Total Volumetric Bone Mineral Density  
A two-way ANOVA shows that there was a significant increase in vBMD at the 
proximal tibia; however, there are no significant differences in post training values 
among groups (PP, IP & PI).  Total vBMD increases by 5.25% at the proximal tibia in 
the PP group (p<0.05) (Fig. 14). 
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Fig. 14. Proximal total volumetric bone mineral density.  Total vBMD of the proximal 
tibia after 21 days of simulated resistance training.  
  * p<0.05 vs. pre value 
 
 
Bone Formation Rate 
 
 This analysis is performed with excised bone, which means the following data 
represents bone formation rate of the final week of our experiment.  Since pre and post 
values were unable to be obtained all exercised leg data (left leg) is compared to the non-
exercised right leg at day 21.   Simulated resistance training results in a significantly 
greater periosteal %MS/BS, MAR and BFR in the exercised leg compared to the non-
exercised leg.  The PP group mean %MS/BS was 9.85% ± 7.89 in the non-exercised leg 
compared to 78.67% ± 6.75 in the exercised leg (Fig. 15a).  The PP groups mean MAR 
was .57 μg/d ± .54 in the non-exercised leg vs. 2.33 μg/d ± .37 in the exercised leg (Fig. 
15b).  Bone formation rate, which is derived from %MS/BS and MAR, was .07 
μm3/μm2/d ± .08 in the non-exercised leg compared to 1.83 μm3/μm2/d ± .29 in the 
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exercised leg (Fig. 15c) in the PP group.  This large increase in BFR pertains only to 
those surfaces that exhibited lamellar bone growth.  Fig. 15d I, II, III & IV is a visual 
representation of the fluorochrome label observed on the non exercise bone (I & III) and 
the double label observed on the exercised bone (II & IV).  Woven bone, which was an 
unexpected finding detailed below, was not included in these measurements due to the 
difficulty in determining MAR.  Fluorescent labeling of woven bone is smeared and 
does not exhibit distinguishable single or double label.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15.  Bone formation rate.  Dynamic histomorphometry measures for the non 
exercised leg vs. exercised led ■ exercised leg, □ non-exercised leg. a.) %MS/BS of the 
exercised leg is significantly greater than non-exercised leg b.) MAR of the exercised leg 
is significantly greater than non-exercised leg. c.)  BFR of the exercised leg is 
significantly greater than the non-exercised leg. d.) I (100X magnification) & II (200X) 
is a visual representation the of the non-exercised leg fluorochrome label. d.) III (100X) 
& IV (200X) is a visual representation of the exercised leg fluorochrome label.   
% Mineralized Surface (%MS/BS) Mineral Apposition Rate (MAR, μg/d) Bone 
Formation Rate (BFR, μm3/μm2/d) * p<0.05 vs. non-exercise. 
. 
c. 
□ non-exercised leg           ■ exercised leg □ non-exercised leg           ■ exercised 
leg 
□ non-exercised leg           ■ exercised 
leg 
b
. 
a. 
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Woven Bone  
Bone formation rate was measured only on lamellar bone surfaces.  
Unexpectedly, a significant amount of woven bone formation was observed in 100% of 
the exercised leg samples on the periosteal surface.  The woven bone is rapidly formed 
bone due to hyperphysiological loads or uncommon load angles on the bone.  Although 
woven bone contains mineralized bone, much of its composition is collagen and it is 
unorganized compared to lamellar bone.  The simulated resistance training apparently 
produced a unique load on the bone which contributed to the formation of woven bone 
(Fig. 16).  Woven bone compromised as much 14% ± 4 (PP 12± 2%, PI 14 ± 4% & PI 
11± 3) of the total bone area of the tiba cross sections from the exercised legs.  Despite 
this significant gain in woven bone with SRT, there were no significant differences in 
woven bone formation across groups using a two-way ANOVA . 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Woven bone formation.  a.) non-exercised leg b.) exercised leg.  Woven bone 
was observed in the exercised leg due to the simulated resistance training. 
 
 
 
Non-Exercised Leg Exercised Leg 
Lamellar Bone 
Lamellar Bone 
Woven Bone 
a. b. 
Lamellar Bone 
33 
 
Alterations in Serum Interleukin-6 
Interleukin-6 measurements were attempted via an Il-6 ELISA rat assay; 
however, technical limitations of the assay kit disallowed a full analysis.  The standard 
curve (Fig. 17) gives an O.D value of .00561 that corresponds to 0 pg/ml and the O.D. 
that corresponds to 62.5 pg/ml is .03737.  The O.D. values for duplicate samples of 8 
different animal’s serum range from   -.00607 to .038325 (Table 4).  However, after 
plugging these values into the linear equation .0007x-0.0578=y, where y= .O.D., we 
obtained values ranging from 147 pg/ml to 274 pg/ml, after accounting for a dilution 
factor of 2 which is required for all rat serum. At first glance these may seem to be 
reasonable values; however, the animal serum O.D. values fall within range of 0 pg/ml 
to 62.5 pg/ml within the standard curve.  This poses a problem when analyzing the data, 
because results falling below the lowest concentration data point on the standard curve 
are considered undetectable in the rat serum.  This may be because there is no detectible 
systemic Il-6 in rats; however, this is unlikely due to previously published results 
indicating otherwise utilizing the same ELISA Il-6 kit.  An ideal kit would allow us to 
choose from a range of standards spanning the lower concentration range in order to 
detect any changes in Il-6 due to simulated resistance training. 
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Fig. 17. ELISA Il-6 rat serum standard curve.  R2 0.9957. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Standard curve O.D. was obtained through creating a standard curve with known pg/ml 
samples.  The corresponding animal O.D. indicates that all of the obtained animal 
sample values are < 62.5 pg/ml and therefore undetectable. 
 
 
 
 
Standard Curve     
      pg/ml 
Corrected 
O.D. 
  
Animal O.D. 
0 0.00561   -0.00607 
62.5 0.03737   0.004905 
125 0.0542   0.00724 
250 0.12325   0.038325 
500 0.28324   -0.005625 
1000 0.52361   0.0025 
2000 1.35719   0.00551 
4000 2.87421   0.001035 
Table 4  
Il-6 rat serum standard curve and O.D. values. 
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CHAPTER V 
DISCUSSION 
 Ongoing studies have identified various windows in which mechanically-induced 
PGE2 is thought to have its effect on bone formation.  These animal studies are limited to 
an acute bout of exercise and have yet to establish the impact of NSAID use with 
repeated bouts of exercise.  To our knowledge, there is only one published study in 
which researchers expanded the acute response studies to a long-term training study, 
testing the impact of ibuprofen in exercising pre-menopausal females [4].  Kohrt et al. 
(2010) demonstrated that if ibuprofen is taken after exercise there is an enhanced gain in 
bone mass over a period of 9 months.  The aim of this thesis study was to bridge the gap 
between the original acute loading animal studies and the more recent human training 
model using simulated resistance training in rats. 
 Our first hypothesis, that bone formation rate will be suppressed over time in rats 
given ibuprofen before each training session but enhanced if ibuprofen is given after 
each exercise bout, is not supported by our results.  Previous acute loading studies show 
that when NSAIDs are administered 3 hours before loading there is a suppression of the 
usual increase in bone formation rate [1]; however, this inhibitory effect of NSAIDs is 
not reflected in our results after repeated bouts of loading provided by the simulated 
resistance training.  Bone formation rate significantly increased over the course of three 
weeks due to simulated resistance training regardless of when or if ibuprofen was given 
with no significant differences among groups.  These results may be confounded by the 
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unexpected find of woven bone on the periosteal and endosteal surfaces of tibiae in the 
trained legs.    
 Woven bone is structurally unorganized, low in mineral density and is formed 
rapidly.   It can result due to bone damage, hyperphysiological loading or unique loading 
angles [6].  In the past, woven bone was primarily associated with trauma to the bone, as 
suggested by Frost (1988) [37]. However, Lanyon et al. (1982) [38] demonstrated that 
hyperphysiological (but not pathological) loads imposed on a turkey ulna will produce 
woven bone on the periosteal surface that eventually consolidates into lamellar bone if 
loading continues for at least 6 weeks.  Our loading protocol using moderate intensity 
muscle contractions (similar to 75% 1 RM) produced robust formation of woven bone.  
Since 75% of 1 RM is not considered “high intensity” by humans performing resistance 
training, this leads us to speculate that the stimulated muscle contractions may be 
imposing unique directional forces on the tibia, providing a unique strain distribution on 
the bone.  Visual analysis of the tibiae cross sections at the tibular-fibular junction 
indicated woven bone production in every sample analyzed of the exercised leg 
consistently on the anterior periosteal surface, but not the posterior periosteal surface 
suggesting an isolated load where the woven bone production was observed.  The robust 
response to our loading protocol, evidence by woven bone formation and large gains in 
BFR at lamellar surfaces may overshadow more subtle effects of ibuprofen on bone 
formation rate.  Thus, we are unable to make any definitive conclusions on the timing of 
ibuprofen and its impact on bone formation rate. 
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 Bone mass did significantly increase in every group over the course of 3 weeks; 
however, much like bone area and density gain, there were no significant differences in 
bone formation rate among ibuprofen or placebo-treated groups.  Kohrt et al. (2010) 
demonstrated in adult female subjects magnified gains in bone mineral density if 
ibuprofen was administered after exercise training over the course of 9 months.  
Although our results do not reflect those previous results in humans, we cannot ignore 
the woven bone response observed at the tibular-fibular junction described previously.  
Any effect that may have been exerted by ibuprofen administration may have been 
washed out by the unique physiological load placed on our animals.   
 One key limitation of our study is the lack of selectivity of ibuprofen to the 
COX-2 enzyme.  COX-2 isoform is the main contributor to mechanical-induced PGE2 in 
bone. As previously described, ibuprofen is less selective to COX-2 than the originally 
used indomethacin and NS-398.  Because ibuprofen actually has a greater affinity 
towards COX-1 than COX2, it may not adequately suppress PGE2 in order to provide the 
inhibition of bone formation response as observed with indomethacin and NS-398. 
 Another key limitation to our results is our inability to confirm in these animals 
that ibuprofen had an effect on PGE2 signaling in bone.  This was because samples were 
saved as serum and not plasma which is necessary for PGE2 analysis.  Furthermore, 
PGE2 analysis requires indomethacin immediately after blood is drawn in order to inhibit 
an ex-vivo synthesis.  Our dose of 30 mg/kg has effectively been used in fracture healing 
studies [33, 34]. Also, Rissing and Buxton (1986) showed an effect on the PGE2 levels 
assessed by radioimmunoassay in animals treated with 30 mg/kg/day of ibuprofen in 
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Sprague Dawley rats.  Unfortunately, we do not have any data on altered PGE2 levels in 
bone or serum to confirm that our administration of ibuprofen effectively modulated 
PGE2 levels before or after our loading regimen.   
 Originally, we attempted to determine IL-6 serum levels after an acute exercise 
bout in order to suggest a mechanism for ibuprofen’s effect on bone if given after 
exercise; however, our attempts at quantifying serum IL-6 were unsuccessful, due to the 
limitation of the assay kit purchased.  Since we could not reproduce the enhanced bone 
gain demonstrated by Kohrt et al. (2010), with ibuprofen given post-exercise, 
determining mechanisms became a moot issue.  The attempt to measure IL-6 would 
have, however, served to test the efficacy of our delivery method with the animals; 
because of ibuprofen’s ant-inflammatory properties, we would have expected to see 
suppressed serum IL-6 levels in animals that received ibuprofen after SRT.  Previously 
published data have demonstrated an increase in IL-6 mRNA levels, with simulated 
resistance training in rats [24] and in serum levels in humans after vigorous exercise 
[17]. 
   In order to successfully bridge the gap between previous animal studies and 
recent human studies, it will be necessary to develop an adequate phenotype in order to 
test any future hypotheses.  Although mechanical loading studies have already 
established that bone formation rate is suppressed when NSAIDs are administered before 
exercise, our mechanical loading device provides a loading stimulus that differs from 
previous studies. We are stimulating the surrounding muscles to actively contract rather 
than bending the bone directly without muscle contraction, as described in ulna loading 
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studies [1].  It would be desirable to perform a dose response study varying intensity of 
muscle contractions, in order to test the effectiveness of intensities ranging from 25% 
1RM to 75% 1RM in stimulating formation of the more organized lamellar bone.  Turner 
et al. (1994) [39] has demonstrated that the adaptive response of woven bone to 
hyperphysiological loads is dependent on a threshold, showing that woven bone 
response was either absent with lower mechanical stimulus or responded at a maximal 
rate if the stimulus threshold was surpassed.  A dose response study would hopefully 
suppress the woven bone production and thus reveal any effect of ibuprofen on that bone 
formation response.  Once an adequate phenotype is established, then a more appropriate 
training model can be tested. 
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CHAPTER VI 
CONCLUSION 
Non-steroidal anti-inflammatory drugs (NSAIDs) are used by millions across the 
globe to treat for musculoskeletal pain and inflammation. The use of these drugs, 
however, has been shown to reduce the anabolic response to bone after an acute bout of 
exercise in animal models.  These studies are thus far focused on an acute bout of 
exercise and have yet to establish the impact of NSAIDs with chronic exposure to 
exercise (training).  One study in humans has successfully demonstrated an enhanced 
response of bone to training if ibuprofen is administered after each exercise bout [4].  
The aim of this thesis study was to bridge the gap between the original acute loading 
animal studies and the more recent human training model by using repeated bouts of 
simulated resistance training in rats. 
 We were able to produce a robust gain in bone formation rate and bone mass, but 
were unable to detect any change in bone response to the simulated resistance training 
with ibuprofen.  The robust increase in bone formation indicated by new woven bon, 
have overshadowed more subtle effects of ibuprofen on bone formation rate.  Thus, we 
are unable to make any definitive conclusions on the timing of ibuprofen and its impact 
on exercise-induced bone formation rate or bone mass.  Future studies are worth 
pursuing based on the potential therapeutic effects of ibuprofen when taking after 
exercise [4].  It is still necessary to understand the mechanism of her findings via animal 
studies in order to optimize any potential benefits in a therapeutic setting. 
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